CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment

Since 1989, four Canadian Consensus Conferences on the Diagnosis and Treatment of Dementia (CCCDTDs) have provided evidence‐based dementia diagnostic and treatment guidelines for Canadian clinicians and researchers. We present the results from the Neuroimaging and Fluid Biomarkers Group of the 5th C...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Alzheimers Dement (N Y)
Auteurs principaux: Brisson, Mélanie, Brodeur, Catherine, Létourneau‐Guillon, Laurent, Masellis, Mario, Stoessl, Jon, Tamm, Alex, Zukotynski, Katherine, Ismail, Zahinoor, Gauthier, Serge, Rosa‐Neto, Pedro, Soucy, Jean‐Paul
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2021
Sujets:
Review Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7821956/
https://ncbi.nlm.nih.gov/pubmed/33532543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12098
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires